Literature DB >> 8219191

Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1.

R Hromas1, A Orazi, R S Neiman, R Maki, C Van Beveran, J Moore, M Klemsz.   

Abstract

The ETS oncogene family member PU.1 is a transcriptional activator that is dysregulated by Friend erythroleukemia virus insertion. Northern analysis found that PU.1 is highly expressed in cells of myeloid and B-lymphoid origin, but not expressed at all in a number of nonhematopoietic tissues. Interferon-gamma and retinoic acid downregulated PU.1 expression in marrow macrophages. In situ immunohistochemistry found that PU.1 is expressed only in early granulocytic and erythroid cells and megakaryocytes, but not in mature erythroid cells, mature granulocytes, endothelial cells, or osteocytes. Thus, its expression pattern makes PU.1 a candidate for a genetic determinant of lineage commitment and stage progression in blood cell development. It also lends insight into how PU.1 might play a role in Friend virus erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219191

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Down-regulation of the myeloid homeobox protein Hex is essential for normal T-cell development.

Authors:  David L Mack; David S Leibowitz; Scott Cooper; Heather Ramsey; Hal E Broxmeyer; Robert Hromas
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 3.  GATA transcription factors in hematologic disease.

Authors:  Alan B Cantor
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

4.  Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.

Authors:  Henrietta Szutorisz; Claudia Canzonetta; Andrew Georgiou; Cheok-Man Chow; László Tora; Niall Dillon
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Authors:  Giorgia Santilli; Elena Almarza; Christian Brendel; Uimook Choi; Chiara Beilin; Michael P Blundell; Sneha Haria; Kathryn L Parsley; Christine Kinnon; Harry L Malech; Juan A Bueren; Manuel Grez; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-10-26       Impact factor: 11.454

6.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

7.  Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.

Authors:  G H Su; H M Chen; N Muthusamy; L A Garrett-Sinha; D Baunoch; D G Tenen; M C Simon
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.

Authors:  Steven D Rhodes; Hao Yang; Ruizhi Dong; Keshav Menon; Yongzheng He; Zhaomin Li; Shi Chen; Karl W Staser; Li Jiang; Xiaohua Wu; Xianlin Yang; Xianghong Peng; Khalid S Mohammad; Theresa A Guise; Mingjiang Xu; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

9.  Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia.

Authors:  F Mélet; B Motro; D J Rossi; L Zhang; A Bernstein
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

10.  Gene profiling of the erythro- and megakaryoblastic leukaemias induced by the Graffi murine retrovirus.

Authors:  Veronique Voisin; Philippe Legault; Diana Paulina Salazar Ospina; Yaacov Ben-David; Eric Rassart
Journal:  BMC Med Genomics       Date:  2010-01-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.